Hermed Capital Co. Ltd.

General contacts
Investor type

VC

Founded

2015

AUM

-

Location

Shanghai, Shanghai, China

Investment Ticket

$5-10 m

Investment Stage

Pre-seed Seed Series A Series B

Region of investment

North America Asia
Investor profile last updated: 18 August, 2026

Profile

Hermed Capital Co. Ltd. is a healthcare-focused investment firm headquartered in Shanghai, China. Founded in 2015, the firm has built a dedicated team specializing in investment in the healthcare sector. Their team is comprised of experienced professionals who bring a wealth of knowledge from various backgrounds, distinguishing themselves with a deep understanding of the Chinese healthcare market.

The firm invests primarily in the health sector, including biotechnology, pharmaceuticals, healthcare services, and medical devices. Hermed Capital typically invests in various stages of company development, including early-stage to late-stage growth. They focus predominantly on opportunities within China, operating with a nuanced understanding of the local healthcare landscape.

Notable investments by Hermed Capital include Applied StemCell - a biotechnology company, Henlius - a leading biopharmaceutical company, Henlix TW - part of the biopharmaceutical industry, and AADi Bioscience - a clinical-stage biopharmaceutical company. These investments demonstrate Hermed Capital's strategic focus on advancing healthcare innovation and supporting companies that offer significant potential in the sector.

Industry

Healthcare Services Biotechnology Pharmaceuticals Medical Devices

Contacts

Name
Title
Email
Social Networks
avatar
Xiao Zhenyu Managing Director
Managing Director
x•••@•••
avatar
Philip Cui Chairman
Chairman
-
Upgrade to see contacts
avatar
IQfwcPvN68O4qKod IQfwcPvN68O4qKod
IQfwcPvN68O4qKod
[email protected]
linkedin twitter
avatar
IQfwcPvN68O4qKod IQfwcPvN68O4qKod
IQfwcPvN68O4qKod
[email protected]
linkedin twitter
avatar
IQfwcPvN68O4qKod IQfwcPvN68O4qKod
IQfwcPvN68O4qKod
[email protected]
linkedin twitter
Investment-team contacts for Hermed Capital Co. Ltd. — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Hermed Capital Co. Ltd.

Hermed Capital Co. Ltd. is a venture capital firm. It backs companies at Pre-seed, Seed, Series A and Series B, writing tickets of $5-10 m.
Hermed Capital Co. Ltd. is located in Shanghai, Shanghai, China.
Hermed Capital Co. Ltd. was founded in 2015.
Hermed Capital Co. Ltd. invests in companies and startups in Healthcare Services, Biotechnology, Pharmaceuticals, Medical Devices.
Hermed Capital Co. Ltd. invests in companies and startups in North America, Asia.
Hermed Capital Co. Ltd. invests in companies and startups at Pre-seed, Seed, Series A, Series B.
Hermed Capital Co. Ltd. usually invests $5-10 m on average.
Hermed Capital Co. Ltd. can be reached through its website hermedcapital.com. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Hermed Capital Co. Ltd. — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Hermed Capital Co. Ltd. directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 18 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.